Constitutive activation of BMP signalling abrogates experimental metastasis of OVCA429 cells via reduced cell adhesion

Journal of Ovarian Research

Volumn 3, Issue 1, 2010, Pages

  Shepherd, Trevor G ^a,b,c   Mujoomdar, Michelle L ^a   Nachtigal, Mark W ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXY 1 METHYLTETRALIN; BETA1 INTEGRIN; BETA3 INTEGRIN; BONE MORPHOGENETIC PROTEIN 4; DOXYCYCLINE; FIBRONECTIN; MESSENGER RNA; UVOMORULIN; VITRONECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; CANCER CELL CULTURE; CANCER TRANSPLANTATION; CELL ADHESION; CELL INVASION; CELL MOTILITY; CELL STRAIN OVCA429; CELL STRUCTURE; CONTROLLED STUDY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; GENE ACTIVATION; HUMAN; HUMAN CELL; MESENCHYME; METASTASIS POTENTIAL; MOUSE; NONHUMAN; OVARY CARCINOMA; PERITONEUM; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPHEROID CELL;

EID: 77953381842     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-3-5     Document Type: Article

References (55)

1. Ovarian cancer metastasis: integrating insights from disparate model organisms. H Naora DJ Montell, Nat Rev Cancer 2005 5 355 66 10.1038/nrc1611 15864277
2. Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells. TG Shepherd MW Nachtigal, Endocrinology 2003 144 3306 14 10.1210/en.2003-0185 12865307
3. Signal transduction of bone morphogenetic protein receptors. A Nohe E Keating P Knaus NO Peterson, Cell Signalling 2004 16 291 9 10.1016/j.cellsig. 2003.08.011 14687659
4. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. A Hartung K Bitton-Worms MM Rechtman V Wenzel JH Boergermann S Hassel YI Henis P Knaus, Mol Cell Biol 2006 26 7791 805 10.1128/MCB.00022-06 16923969
5. Smads as transcriptional co-modulators. L Attisano JL Wrana, Curr Opin Cell Biol 2000 12 235 43 10.1016/S0955-0674(99)00081-2 10712925
6. Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP-dependent dendritogenesis. ST Lee-Hoeflich CG Causing M Podkowa X Zhao JL Wrana L Attisano, Embo J 2004 23 4792 801 10.1038/sj.emboj.7600418 15538389
7. Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. VC Foletta Lim MA J Soosairajah AP Kelly EG Stanley M Shannon W He S Das J Massague O Bernard, J Cell Biol 2003 162 1089 98 10.1083/jcb.200212060 12963706
8. The two faces of transforming growth factor in carcinogenesis. AB Roberts LM Wakefield, Proc Natl Acad Sci USA 2003 100 8621 3 10.1073/pnas.1633291100 12861075
9. From developmental disorder to heritable cancer: it's all in the BMP/TGF-b family. KA Waite C Eng, Nat Rev Genet 2003 4 763 73 10.1038/nrg1178 14526373
10. BMP4 signaling induces senescence and modulates the oncogenic phenotype of A549 lung adenocarcinoma cells. S Buckley W Shi B Driscoll A Ferrario K Anderson D Warburton, Am J Physiol Lung Cell Mol Physiol 2004 286 81 6 10.1152/ajplung.00160.2003 12959928
11. Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. O Hjertner H Hjorth-Hansen M Borset C Seidel A Waage A Sundan, Blood 2001 97 516 22 10.1182/blood.V97.2.516 11154231
12. Growth regulation of human prostate cancer cells by bone morphogenetic protein-2. H Ide T Yoshida N Matsumoto K Aoki Y Osada T Sugimura M Terada, Cancer Res 1997 57 5022 7 9371496
13. Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3. C Kawamura M Kizaki K Yamato H Uchida Y Fukuchi Y Hattori T Koseki T Nishihara Y Ikeda, Blood 2000 96 2005 11 10979940
14. Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Ro TB RU Holt AT Brenne H Hjorth-Hansen A Waage O Hjertner A Sundan M Borset, Oncogene 2004 23 3024 32 10.1038/sj.onc.1207386 14691444
15. Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos/jun family members. S Wach P Schirmacher M Protschka M Blessing, Oncogene 2001 20 7761 9 10.1038/sj.onc.1204962 11753654
16. Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours. N Yamada M Kato P ten Dijke H Yamashita TK Sampath CH Heldin K Miyazono K Funa, Br J Cancer 1996 73 624 9 8605097
17. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. JR Howe JL Bair MG Sayed ME Anderson FA Mitros GM Peterson VE Velculescu G Traverso B Vogelstein, Nat Genetics 2001 28 184 7 10.1038/88919 (Pubitemid 32538067)
18. Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis. MG Sayed AF Ahmed JR Ringold ME Anderson JL Blair FA Mitros H.T L ST Tinley GM Peterson FM Giardiello B Vogelstein J.R Howe, Ann Surg Oncol 2002 9 901 6 10.1007/BF02557528 12417513
19. Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies. P Autzen CN Robson A Bjartell AJ Malcolm MI Johnson DE Neal FC Hamdy, Br J Cancer 1998 78 1219 23 9820184
20. Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue. FC Hamdy P Autzen MC Robinson CH Horne DE Neal CN Robson, Cancer Res 1997 57 4427 31 9331107
21. Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues. IY Kim DH Lee HJ Ahn H Tokunaga W Song LM Devereaux D Jin TK Sampath RA Morton, Cancer Res 2000 60 2840 4 10850425
22. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. EM Langenfeld J Langenfeld, Mol Cancer Res 2004 2 141 9 15037653
23. BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. BL Theriault TG Shepherd M Mujoomdar MW Nachtigal, Carcinogenesis 2007 28 1153 1162 10.1093/carcin/bgm015 17272306
24. Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer. TJ Shaw MK Senterman K Dawson CA Crane BC Vanderhyden, Mol Therapy 2004 10 1032 1042 10.1016/j.ymthe.2004.08.013 (Pubitemid 39625247)
25. Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients. TG Shepherd BL Theriault EJ Campbell MW Nachtigal, Nat Protocols 2006 1 2643 2649 10.1038/nprot.2006.328
26. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. KJ Livak TD Schmittgen, Methods 2001 25 402 8 10.1006/meth.2001.1262 11846609
27. Adenosine down-regulates the surface expression of dipeptidyl peptidase IV on HT-29 human colorectal carcinoma cells: implications for cancer cell behavior. Tan EY M Mujoomdar J Blay, Am J Pathol 2004 165 319 30 15215186
28. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. PA Hoodless T Haerry S Abdollah M Stapleton MB O'Connor L Attisano JL Wrana, Cell 1996 85 489 500 10.1016/S0092-8674(00)81250-7 8653785
29. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. V Bolos H Peinado MA Perez-Moreno MF Fraga M Esteller A Cano, J Cell Sci 2003 116 499 511 10.1242/jcs.00224 12508111
30. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. E Batlle E Sancho C Franci D Dominguez M Monfar J Baulida A Garcia De Herreros, Nat Cell Biol 2000 2 84 9 10.1038/35000034 10655587
31. Ovarian surface epithelium: biology, endocrinology, and pathology. N Auersperg AS Wong KC Choi SK Kang PC Leung, Endocr Rev 2001 22 255 88 10.1210/er.22.2.255 11294827
32. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis. CD Capo-Chichi ER Smith DH Yang IH Roland L Vanderveer C Cohen TC Hamilton AK Godwin XX Xu, Cancer 2002 95 1802 15 10.1002/cncr.10870 12365030
33. Multicellular spheroids in ovarian cancer metastases: Biology and pathology. K Shield ML Ackland N Ahmed GE Rice, Gynecol Oncol 2009 113 143 8 10.1016/j.ygyno.2008.11.032 19135710
34. Recent advances in three-dimensional multicellular spheroid culture for biomedical research. RZ Lin HY Chang, Biotechnol J 2008 3 1172 84 10.1002/biot.200700228 18566957
35. Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells. F Pouliot A Blais C Labrie, Cancer Res 2003 63 277 81 12543773
36. BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells. H Miyazaki T Watabe T Kitamura K Miyazono, Oncogene 2004 23 9326 35 10.1038/sj.onc.1208127 15531927
37. Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells. IY Kim DH Lee DK Lee HJ Ahn MM Kim SJ Kim RA Morton, Oncogene 2004 23 7651 9 10.1038/sj.onc.1207924 15354178
38. Epithelial-mesenchymal transitions in development and pathologies. JP Thiery, Curr Opin Cell Biol 2003 15 740 6 10.1016/j.ceb.2003.10.006 14644200
39. Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level. NK Kurrey K A SA Bapat, Gynecol Oncol 2005 97 155 65 10.1016/j.ygyno.2004.12.043 15790452
40. Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. N Ahmed EW Thompson MA Quinn, J Cell Physiol 2007 213 581 8 10.1002/jcp.21240 17708542
41. E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. N Auersperg J Pan BD Grove T Peterson J Fisher S Maines-Bandiera A Somasiri CD Roskelley, Proc Natl Acad Sci USA 1999 96 6249 54 10.1073/pnas.96.11.6249 10339573
42. An ovarian adenocarcinoma line derived from SV40/E-cadherin-transfected normal human ovarian surface epithelium. A Ong SL Maines-Bandiera CD Roskelley N Auersperg, Int J Cancer 2000 85 430 7 10.1002/(SICI)1097-0215(20000201)85: 3<430::AID-IJC213.0.CO;2-Q 10652437
43. BMP-2 signaling in ovarian cancer and its association with poor prognosis. C Le Page ML Puiffe L Meunier M Zietarska M de Ladurantaye PN Tonin D Provencher AM Mes-Masson, J Ovarian Res 2009 2 4 10.1186/1757-2215-2-4 19366455
44. Alphavbeta integrins play an essential role in BMP-2 induction of osteoblast differentiation. CF Lai SL Cheng, J Bone Miner Res 2005 20 330 40 10.1359/JBMR.041013 15647827
45. Mechanism of BMP-2 stimulated adhesion of osteoblastic cells to titanium alloy. AK Shah J Lazatin RK Sinha T Lennox NJ Hickok RS Tuan, Biol Cell 1999 91 131 42 10.1016/S0248-4900(99)80037-9 10399828
46. Enhancement of fibronectin synthesis and fibrillogenesis by BMP-4 in cultured rat osteoblast. CH Tang RS Yang HC Liou WM Fu, J Bone Miner Res 2003 18 502 11 10.1359/jbmr.2003.18.3.502 12619935
47. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. DE White NA Kurpios D Zuo JA Hassell S Blaess U Mueller WJ Muller, Cancer Cell 2004 6 159 70 10.1016/j.ccr.2004.06.025 15324699
48. CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. K Lessan DJ Aguiar T Oegema L Siebenson AP Skubitz, Am J Pathol 1999 154 1525 37 10329605
49. Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer. SA Cannistra C Ottensmeier J Niloff B Orta J DiCarlo, Gynecol Oncol 1995 58 216 25 10.1006/gyno.1995.1214 7542622
50. Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. T Strobel SA Cannistra, Gynecol Oncol 1999 73 362 7 10.1006/gyno.1999.5388 10366461
51. Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids. RC Casey KM Burleson KM Skubitz SE Pambuccian TR Oegema Jr LE Ruff AP Skubitz, Am J Pathol 2001 159 2071 80 11733357
52. Integrin alpha(v)beta(3)/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells. S Hapke H Kessler N Arroyo de Prada A Benge M Schmitt E Lengyel U Reuning, J Biol Chem 2001 276 0 8 10.1074/jbc.M100181200 (Pubitemid 37412851)
53. Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v)beta3/vitronectin interaction. S Hapke H Kessler B Luber A Benge P Hutzler H Hofler M Schmitt U Reuning, Biol Chem 2003 384 1073 83 10.1515/BC.2003.120 12956424
54. {beta}3-Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer. S Kaur HA Kenny S Jagadeeswaran MR Zillhardt AG Montag E Kistner SD Yamada AK Mitra E Lengyel, Am J Pathol 2009 175 2184 96 10.2353/ajpath.2009.090028 19808644
55. Bone morphogenetic protein 2 stimulation of tumour growth involves the activation of Smad-1/5. EM Langenfeld Y Kong J Langenfeld, Oncogene 2006 25 685 92 10.1038/sj.onc.1209110 16247476